Kharbanda K, Sarkar C, Dinda A K, Karak A K, Mathur M, Roy S
Department of Pathology, All India Institute of Medical Sciences, New Delhi.
Acta Oncol. 1993;32(3):301-6. doi: 10.3109/02841869309093599.
Astrocytomas of different grades of malignancy were cultured as primary explant and their sequential growth pattern, glial fibrillary acidic protein (GFAP) expression and labelling index (LI) using bromodeoxyuridine (BrdU) were assessed and correlated with the grade of malignancy of the original tumor tissue. Low-grade astrocytomas showed patterns of growth that diverged from anaplastic astrocytomas and glioblastoma multiforme. The GFAP expression decreased with increasing time in culture in all astrocytomas irrespective of the grading. Maximum GFAP was, however, expressed in the morphologically well-differentiated stellate cells. Contrary to expectations, lower BrdU LI was observed in glioblastoma multiforme in comparison to low-grade astrocytomas, which suggests some unidentified mechanism of differentiation in vitro for astrocytomas of higher grade of malignancy. Hence, in contrast to reported literature on the prognostic value of studies on primary cultures, the present study cautions the extrapolation of the in vitro findings for astrocytomas.
将不同恶性程度的星形细胞瘤作为原代外植体进行培养,并评估其连续生长模式、胶质纤维酸性蛋白(GFAP)表达以及使用溴脱氧尿苷(BrdU)的标记指数(LI),并将这些结果与原始肿瘤组织的恶性程度相关联。低级别星形细胞瘤表现出与间变性星形细胞瘤和多形性胶质母细胞瘤不同的生长模式。在所有星形细胞瘤中,无论分级如何,GFAP表达均随培养时间的增加而降低。然而,最大的GFAP表达见于形态学上分化良好的星状细胞。与预期相反,多形性胶质母细胞瘤中的BrdU LI低于低级别星形细胞瘤,这表明高级别恶性星形细胞瘤在体外存在一些未明确的分化机制。因此,与关于原代培养研究预后价值的报道文献相反,本研究提醒人们谨慎将星形细胞瘤的体外研究结果进行外推。